×

Health Care Equipment and Supplies John Hammergren

  • "Although we were unfavorably impacted in the third quarter by weaker branded pharmaceutical pricing than anticipated, we are updating our fiscal 2017 outlook to reflect McKesson's lower full-year effective tax rate," CEO John Hammergren said in a statement on Wednesday. "We would have preferred that McKesson focus its M&A strategy more on healthcare...

  • Net income attributable to McKesson was $633 million, or $2.85 per share, in the third quarter ended Dec. 31, from $634 million, or $2.73 per share, a year earlier. Revenue rose to $50.13 billion from about $47.90 billion, compared with estimates of about $50.50 billion. McKesson said on Wednesday it expects adjusted earnings from continuing operations of $12.60-...

  • Jan 17- McKesson Corp, one of the largest U.S. distributors of pharmaceutical drugs, will pay a record $150 million to resolve a U.S. investigation into whether it failed to report suspicious orders of addictive painkillers. Tuesday's deal with the U.S. Justice Department followed an earlier settlement with the company over similar violations in 2008.